Listed

CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2014

Filed with the SEC on Aug 5, 2014 and accepted by EDGAR at Aug 5, 2014, 16:49 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-04-01 to 2014-06-30$34.60bnus-gaap:Revenues
Revenue6 months2014-01-01 to 2014-06-30$67.29bnus-gaap:Revenues
Cost of revenue3 months2014-04-01 to 2014-06-30$28.28bnus-gaap:CostOfRevenue
Cost of revenue6 months2014-01-01 to 2014-06-30$55.02bnus-gaap:CostOfRevenue
Gross profit3 months2014-04-01 to 2014-06-30$6.32bnus-gaap:GrossProfit
Gross profit6 months2014-01-01 to 2014-06-30$12.27bnus-gaap:GrossProfit
Operating income3 months2014-04-01 to 2014-06-30$2.21bnus-gaap:OperatingIncomeLoss
Operating income6 months2014-01-01 to 2014-06-30$4.23bnus-gaap:OperatingIncomeLoss
Interest expense3 months2014-04-01 to 2014-06-30$161.0mus-gaap:InterestExpense
Interest expense6 months2014-01-01 to 2014-06-30$322.0mus-gaap:InterestExpense
Income tax3 months2014-04-01 to 2014-06-30$804.0mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2014-01-01 to 2014-06-30$1.54bnus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-04-01 to 2014-06-30$1.25bnus-gaap:ProfitLoss
Net income6 months2014-01-01 to 2014-06-30$2.38bnus-gaap:ProfitLoss
Diluted EPS3 months2014-04-01 to 2014-06-30$1.06us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2014-01-01 to 2014-06-30$2.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-04-01 to 2014-06-30$1.07us-gaap:EarningsPerShareBasic
Basic EPS6 months2014-01-01 to 2014-06-30$2.03us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-04-01 to 2014-06-301,174,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2014-01-01 to 2014-06-301,182,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2014-01-01 to 2014-06-30$3.07bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2014-01-01 to 2014-06-30$891.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2014-01-01 to 2014-06-30$647.0mus-gaap:PaymentsOfDividends
Share repurchases6 months2014-01-01 to 2014-06-30$2.00bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-06-30$1.61bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-06-30$24.14bnus-gaap:AssetsCurrent
Total assetsAt period end2014-06-30$72.59bnus-gaap:Assets
Current liabilitiesAt period end2014-06-30$16.63bnus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2014-06-30$38.13bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-14-000028. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.